Skip to content
TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
-$43.51M+28.2%-$60.61M+8.6%-$66.28M-0.6%-$65.89M-2.4%-$64.36M+0.5%
$6.78M-2.4%$6.94M-1.1%$7.02M+2.2%$6.87M+4.4%$6.58M+4.7%
$4.78M+5.0%$4.55M+0.6%$4.52M-23.2%$5.89M-30.9%$8.52M-23.6%
-$23.82M-113%-$11.19M+32.8%-$16.65M+39.6%
$3.91M+22.3%$3.2M-17.8%$3.9M
-$3.91M-27.3%-$3.07M-52.6%-$2.01M-122%$8.99M-68.3%$28.38M-40.8%
$20M
$16.27M+40.8%$11.56M+50.9%$7.66M+341%-$3.18M+56.3%-$7.29M-109%
-$19.74M-222%-$6.13M-266%$3.68M-77.2%
-$27.9M+6.9%-$29.96M

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does The Oncology Institute, Inc. generate?
The Oncology Institute, Inc. (TOI) generated -$30.0M in operating cash flow over the trailing twelve months.
What is The Oncology Institute, Inc.'s free cash flow?
After $3.9M of capital expenditures, The Oncology Institute, Inc.'s free cash flow was -$27.9M over the trailing twelve months, up 36.7% year over year.
Where does The Oncology Institute, Inc.'s cash flow data come from?
Every line is extracted from The Oncology Institute, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.